Niquitin Fresh Mint (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Niquitin Fresh Mint, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It treats nicotine dependence and helps adults who want to quit smoking. GNH USA supplies Niquitin Fresh Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine Resinate is used in nicotine replacement therapy to aid smoking cessation.

- Smoking cessation: reduces nicotine withdrawal symptoms in adults who want to quit smoking. - Tobacco dependence: provides controlled nicotine delivery to support gradual reduction of nicotine intake. - Relapse prevention: helps maintain abstinence after quitting by alleviating cravings.

Adverse reactions may occur with oromucosal nicotine products.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: discomfort or scratchy sensation. - Nausea: occasional upset stomach. - Dizziness: transient light‑headedness. - Headache: mild to moderate intensity. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexplained discomfort in the chest area. - Palpitations: irregular or rapid heartbeats. - Severe hypotension: marked drop in blood pressure causing faintness. - Respiratory depression: difficulty breathing, especially in high‑risk individuals.

When using Niquitin Fresh Mint, consider the following safety measures. - Assess nicotine dependence: determine the appropriate level of nicotine replacement. - Avoid use in non‑smokers: product is intended for individuals with nicotine addiction. - Do not combine with other nicotine products: may lead to excess nicotine exposure. - Monitor cardiovascular status: patients with heart disease should use under medical supervision. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotine Resinate may interact with certain medications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive events. - CYP2A6 inhibitors: may raise systemic nicotine levels, enhancing side effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Warfarin: nicotine can affect platelet function, requiring INR monitoring. - Antidepressants (SSRIs): potential for altered nicotine metabolism.